Guan Q, Alasmari F, Li C, Mfarrej S, Mukahal M, Arold S
Microbiol Spectr. 2025; 13(3):e0326024.
PMID: 39903450
PMC: 11878057.
DOI: 10.1128/spectrum.03260-24.
Eix E, Nett J
Annu Rev Med. 2024; 76(1):57-67.
PMID: 39656947
PMC: 11808652.
DOI: 10.1146/annurev-med-061523-021233.
Boakye-Yiadom E, Odoom A, Osman A, Ntim O, Kotey F, Ocansey B
Ther Adv Infect Dis. 2024; 11:20499361241297525.
PMID: 39544852
PMC: 11562003.
DOI: 10.1177/20499361241297525.
Di Lorenzo A, Triggiano F, Lopuzzo M, Piccolomo L, Triggiani M, Grasso S
IJID Reg. 2024; 13:100468.
PMID: 39507392
PMC: 11539118.
DOI: 10.1016/j.ijregi.2024.100468.
Honorato L, Artunduaga Bonilla J, Ribeiro da Silva L, Kornetz J, Zamith-Miranda D, Valdez A
Virulence. 2024; 15(1):2413329.
PMID: 39370781
PMC: 11469440.
DOI: 10.1080/21505594.2024.2413329.
Candida auris central line-associated blood stream infection in critically ill patients: the worst end of a bad scenario.
Meawed T, AlNakeera A, Attia O, Hassan N, Anis R
Int Microbiol. 2024; 28(2):377-383.
PMID: 38940863
DOI: 10.1007/s10123-024-00545-3.
: A Systematic Review of a Globally Emerging Fungal Pathogen in Africa.
Osaigbovo I, Ekeng B, Davies A, Ebeigbe E, Bongomin F, Kanyua A
Open Forum Infect Dis. 2024; 11(6):ofad681.
PMID: 38887473
PMC: 11181182.
DOI: 10.1093/ofid/ofad681.
Description of Occurrence in a Tertiary Health Institution in Riyadh, Saudi Arabia.
Alshahrani F, Elgujja A, Alsubaie S, Ezreqat S, Albarraq A, Barry M
Healthcare (Basel). 2023; 11(24).
PMID: 38132040
PMC: 10743032.
DOI: 10.3390/healthcare11243150.
Mechanisms of pathogenicity for the emerging fungus Candida auris.
Horton M, Holt A, Nett J
PLoS Pathog. 2023; 19(12):e1011843.
PMID: 38127686
PMC: 10735027.
DOI: 10.1371/journal.ppat.1011843.
A Bibliometric Review on of the First Fifteen Years of Research (2009-2023).
Villanueva-Lozano H, Trejo-Castro A, Carrion-Alvarez D, Lozano-Diaz S, Martinez-Torteya A
Biomed Res Int. 2023; 2023:2385018.
PMID: 37869631
PMC: 10586903.
DOI: 10.1155/2023/2385018.
Candida auris: a global pathogen that has taken root in Colombia.
Escandon P, Lockhart S, Chow N, Chiller T
Biomedica. 2023; 43(Sp. 1):278-287.
PMID: 37721898
PMC: 10599714.
DOI: 10.7705/biomedica.7082.
Does repeated exposure to hydrogen peroxide induce Candida auris resistance?.
Cobrado L, Ricardo E, Ramalho P, Fernandes A, Rodrigues A
Antimicrob Resist Infect Control. 2023; 12(1):92.
PMID: 37674229
PMC: 10483791.
DOI: 10.1186/s13756-023-01281-5.
The rapid emergence of antifungal-resistant human-pathogenic fungi.
Lockhart S, Chowdhary A, Gold J
Nat Rev Microbiol. 2023; 21(12):818-832.
PMID: 37648790
PMC: 10859884.
DOI: 10.1038/s41579-023-00960-9.
Identification of Molecular and Genetic Resistance Mechanisms in a Candida auris Isolate in a Tertiary Care Center in Türkiye.
Erturk Sengel B, Ekren B, Sayin E, Cerikcioglu N, Sezerman U, Odabasi Z
Mycopathologia. 2023; 188(6):929-936.
PMID: 37639054
DOI: 10.1007/s11046-023-00787-1.
Evaluation of Anti- Activities of Herbal Preparations Sold at the Kumasi Central Market in the Ashanti Region of Ghana.
Domfeh S, Kyeremeh G, Belifini M
Evid Based Complement Alternat Med. 2023; 2023:6162532.
PMID: 37082250
PMC: 10113043.
DOI: 10.1155/2023/6162532.
Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris Results from a Phase 2 Trial.
Vazquez J, Pappas P, Boffard K, Paruk F, Bien P, Tawadrous M
Antimicrob Agents Chemother. 2023; 67(5):e0141922.
PMID: 37022196
PMC: 10190264.
DOI: 10.1128/aac.01419-22.
Navigating the New Reality: A Review of the Epidemiological, Clinical, and Microbiological Characteristics of , with a Focus on Children.
Ashkenazi-Hoffnung L, Rosenberg Danziger C
J Fungi (Basel). 2023; 9(2).
PMID: 36836291
PMC: 9963988.
DOI: 10.3390/jof9020176.
Identification and Antifungal Drug Susceptibility Pattern of in India.
Deshkar S, Patil N, Amberkar S, Lad A, Siddiqui F, Sharan S
J Glob Infect Dis. 2023; 14(4):131-135.
PMID: 36636301
PMC: 9831210.
DOI: 10.4103/jgid.jgid_44_22.
Undesired Effect of Vancomycin Prolonged Treatment: Enhanced Biofilm Production of the Nosocomial Pathogen .
Maione A, La Pietra A, Salvatore M, Guida M, Galdiero E, de Alteriis E
Antibiotics (Basel). 2022; 11(12).
PMID: 36551428
PMC: 9774269.
DOI: 10.3390/antibiotics11121771.
Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic.
Correa-Junior D, Andrade I, Alves V, S Araujo G, Frases S
Microorganisms. 2022; 10(11).
PMID: 36363816
PMC: 9695014.
DOI: 10.3390/microorganisms10112223.
